FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 342:1291-1292 April 27, 2000 Number 17 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited Related Article by Buxton, A. E.

To the Editor: Buxton et al. (Dec. 16 issue)¹ report that electrophysiologically guided antiarrhythmic therapy, primarily with implantable defibrillators, but not antiarrhythmic drugs, reduces the risk of sudden death in high-risk patients with coronary disease. In Figure 1 of their article, however, the group with electrophysiologically guided therapy actually fared worse than the group with no antiarrhythmic therapy for a good part of the first year; it is only after the first year of enrollment that the two curves begin to diverge and the group receiving electrophysiologically guided therapy begins to show an advantage. No comment was made in the . . . [Full Text of this Article]

References

HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  TERMS OF USE  |  HELP  |  beta.nejm.org Comments and questions? Please contact us. The New England Journal of Medicine is owned, published, and copyrighted © 2009 Massachusetts Medical Society. All rights reserved.